ROS1 (P08922) variants and mutations
ROS1 (also known as P08922) is a human protein-coding gene encoding a proto-oncogene tyrosine-protein kinase ROS protein. Its normal physiologic signaling remains incompletely defined, but chromosomal rearrangement can place its kinase domain under constitutive control. ROS1 fusion kinases are actionable oncogenic drivers in non-small-cell lung cancer and several other tumors. This analysis covers 5,943 ROS1 variants and mutations. Of these, 39% have computational variant effect predictions. Disease context includes non-small cell lung carcinoma, neoplasm, and lung adenocarcinoma. Example ROS1 variants include K2N, N3H, and I4F.
Variant analysis overview
- Gene: ROS1
- Protein: P08922
- UniProt accession: P08922
- Organism: Homo sapiens
- Variants analyzed: 5943
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 5,732 unspecified-consequence records; 86 synonymous variants; 99 missense variants; 12 frameshift variants; 5 stop-gained variants; 3 in-frame deletions; 3 splice-region variants; 3 substitution
- Prediction scores: 2,343 variants have prediction scores (39% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: non-small cell lung carcinoma, neoplasm, lung adenocarcinoma, cancer, lung carcinoma, melanoma, squamous cell lung carcinoma, cutaneous melanoma, spitz nevus, melanocytic neoplasm, lymphoid neoplasm, bile duct carcinoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 10 domains; 2 binding sites; 32 post-translational modification sites.
- Structural context: 3,456 variants have structural context.
- PTM context: 72 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ROS1 variants
Examples include K2N, N3H, I4F, I4V, Y5F, Y5H, C6S, C6Y. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- K2N (p.Lys2Asn), NCI-TCGA Cosmic COSV6385, cosmic curated COSV63854, Ensembl rs2128753497, MetaLR 0.33, MetaSVM -0.39, Variant assessed as somatic; moderate impact.
- N3H (p.Asn3His), gnomAD rs1489703242, REVEL 0.12, MetaLR 0.16
- I4F (p.Ile4Phe), ESP rs369466253, TOPMed rs369466253, gnomAD rs369466253, REVEL 0.16, MetaLR 0.15
- I4V (p.Ile4Val), rs369466253, ESP rs369466253, TOPMed rs369466253, gnomAD rs369466253, REVEL 0.06, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- Y5F (p.Tyr5Phe), Ensembl rs2128753481, MetaLR 0.05, MetaSVM -1.09
- Y5H (p.Tyr5His), gnomAD rs1340793753, REVEL 0.05, MetaLR 0.07
- C6S (p.Cys6Ser), ExAC rs754955040, gnomAD rs754955040
- C6Y (p.Cys6Tyr), ExAC rs754955040, gnomAD rs754955040, REVEL 0.07, MetaLR 0.08
- L7F (p.Leu7Phe), cosmic curated COSV10530, Ensembl rs2128753469
- I8V (p.Ile8Val), TOPMed rs1229447233, gnomAD rs1229447233, REVEL 0.12, MetaLR 0.08
- P9L (p.Pro9Leu), rs770579408, ClinGen CA3976075, cosmic curated COSV63862, ClinVar RCV004449560, REVEL 0.06, MetaLR 0.02, Likely benign, not specified
- P9S (p.Pro9Ser), NCI-TCGA Cosmic COSV6385, cosmic curated COSV63851, MetaLR 0.05, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- K10E (p.Lys10Glu), gnomAD rs1387124417, REVEL 0.12, MetaLR 0.11
- K10N (p.Lys10Asn), 1000Genomes rs531081004, REVEL 0.11, MetaLR 0.11
- L11P (p.Leu11Pro), ExAC rs772804887, TOPMed rs772804887, gnomAD rs772804887, REVEL 0.13, MetaLR 0.13
- L11R (p.Leu11Arg), ExAC rs772804887, TOPMed rs772804887, gnomAD rs772804887, REVEL 0.20, MetaLR 0.13
- V12D (p.Val12Asp), gnomAD rs1776082502, REVEL 0.31, MetaLR 0.15
- V12I (p.Val12Ile), gnomAD rs1429387157
- N13S (p.Asn13Ser), rs45606237, cosmic curated COSV63863, UniProt VAR 041442, 1000Genomes rs45606237, REVEL 0.06, MetaLR 0.06
- A15V (p.Ala15Val), gnomAD rs1170566188, REVEL 0.11, MetaLR 0.07
- T16A (p.Thr16Ala), Ensembl rs1562400875
- T16I (p.Thr16Ile), TOPMed rs1464664635, gnomAD rs1464664635, REVEL 0.08, MetaLR 0.10
- T16L (p.Thr16Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T16N (p.Thr16Asn), TOPMed rs1464664635, gnomAD rs1464664635
- T16P (p.Thr16Pro), cosmic curated COSV10592, Ensembl rs1562400875, Uncertain significance, not specified
- L17F (p.Leu17Phe), ExAC rs776963776, gnomAD rs776963776, REVEL 0.06, MetaLR 0.13
- G18D (p.Gly18Asp), Ensembl rs2128753394
- G18S (p.Gly18Ser), gnomAD rs1435247456, REVEL 0.07, MetaLR 0.13
- G18V (p.Gly18Val), Ensembl rs2128753394, MetaLR 0.11, MetaSVM -0.94
- C19R (p.Cys19Arg), gnomAD rs1179507437, REVEL 0.22, MetaLR 0.14
- C19S (p.Cys19Ser), rs747481675, NCI-TCGA Cosmic COSV6385, cosmic curated COSV63857, ExAC rs747481675, REVEL 0.09, MetaLR 0.12, Variant assessed as somatic; moderate impact.
- C19Y (p.Cys19Tyr), ExAC rs747481675, TOPMed rs747481675, gnomAD rs747481675, REVEL 0.11, MetaLR 0.11, Uncertain significance, not specified
- W21* (p.Trp21Ter), NCI-TCGA TCGA novel, Ensembl rs2128753371, Variant assessed as somatic; high impact.
- W21C (p.Trp21Cys), Ensembl rs2128753371, REVEL 0.55, MetaLR 0.40
- S23F (p.Ser23Phe), rs1562400768, NCI-TCGA Cosmic COSV6385, cosmic curated COSV63857, Ensembl rs1562400768, REVEL 0.44, MetaLR 0.39, Variant assessed as somatic; moderate impact.
- V24A (p.Val24Ala), TOPMed rs1251827246, gnomAD rs1251827246, REVEL 0.11, MetaLR 0.05
- V24E (p.Val24Glu), TOPMed rs1251827246, gnomAD rs1251827246, REVEL 0.18, MetaLR 0.09
- V24L (p.Val24Leu), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Variant assessed as somatic; moderate impact.
- V25L (p.Val25Leu), ExAC rs776025396, TOPMed rs776025396, gnomAD rs776025396
- V25M (p.Val25Met), ExAC rs776025396, TOPMed rs776025396, gnomAD rs776025396, REVEL 0.21, MetaLR 0.09
- Q26* (p.Gln26Ter), Ensembl rs2128753344
- Q26L (p.Gln26Leu), TOPMed rs1776077709
- Q26R (p.Gln26Arg), cosmic curated COSV63862, TOPMed rs1776077709
- C27R (p.Cys27Arg), TOPMed rs1776077506, REVEL 0.34, MetaLR 0.10
- C27Y (p.Cys27Tyr), Ensembl rs2128753334, MetaLR 0.13, MetaSVM -0.96
- T28I (p.Thr28Ile), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, REVEL 0.14, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- T28K (p.Thr28Lys), TOPMed rs924427270, gnomAD rs924427270, REVEL 0.33, MetaLR 0.16
- V29D (p.Val29Asp), TOPMed rs1776076888, REVEL 0.39, MetaLR 0.23
- V29I (p.Val29Ile), Ensembl rs2128753322
- C33G (p.Cys33Gly), TOPMed rs1776076278, MetaLR 0.42, MetaSVM -0.21
- C33Y (p.Cys33Tyr), Ensembl rs2128753295, REVEL 0.60, MetaLR 0.52
- L34V (p.Leu34Val), TOPMed rs1776075738, REVEL 0.07, MetaLR 0.11
- K35N (p.Lys35Asn), TOPMed rs1776075507, gnomAD rs1776075507, REVEL 0.09, MetaLR 0.09, Uncertain significance, not specified
- S36* (p.Ser36Ter), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, CADD 36.00, Variant assessed as somatic; high impact.
- S36L (p.Ser36Leu), gnomAD rs1287982877, REVEL 0.05, MetaLR 0.07
- C37S (p.Cys37Ser), ExAC rs779056086, REVEL 0.52, MetaLR 0.22
- V38A (p.Val38Ala), Ensembl rs746635415, REVEL 0.22, MetaLR 0.20
- V38I (p.Val38Ile), NCI-TCGA TCGA novel, Ensembl rs2128753225, Variant assessed as somatic; moderate impact.
- T39A (p.Thr39Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N40Y (p.Asn40Tyr), Ensembl rs2128753204
- L41R (p.Leu41Arg), TOPMed rs1286253504, gnomAD rs1286253504, REVEL 0.36, MetaLR 0.24
- L41V (p.Leu41Val), cosmic curated COSV10747, ExAC rs757365700, gnomAD rs757365700, REVEL 0.13, MetaLR 0.13
- G42C (p.Gly42Cys), NCI-TCGA Cosmic COSV6385, Variant assessed as somatic; moderate impact.
- G42D (p.Gly42Asp), Ensembl rs2128746482
- G42S (p.Gly42Ser), cosmic curated COSV63856, Ensembl rs1775508919
- Q43R (p.Gln43Arg), TOPMed rs1775508513, REVEL 0.03, MetaLR 0.02
- Q44K (p.Gln44Lys), ESP rs376113207, ExAC rs376113207, TOPMed rs376113207, gnomAD rs376113207, REVEL 0.07, MetaLR 0.17
- L45V (p.Leu45Val), ExAC rs779908946, gnomAD rs779908946
- L47F (p.Leu47Phe), rs1775507306, ClinGen CA365449630, NCI-TCGA Cosmic COSV1008, NCI-TCGA Cosmic COSV6385, REVEL 0.04, MetaLR 0.08, Uncertain significance, not specified
- G48D (p.Gly48Asp), NCI-TCGA Cosmic COSV6385, cosmic curated COSV63852, Ensembl rs2128746440, MetaLR 0.18, MetaSVM -0.64, Variant assessed as somatic; moderate impact.
- G48S (p.Gly48Ser), ExAC rs758251496, gnomAD rs758251496, REVEL 0.06, MetaLR 0.12
- T49A (p.Thr49Ala), TOPMed rs1460150065
- T49I (p.Thr49Ile), cosmic curated COSV10820, gnomAD rs1347271467, MetaLR 0.10, MetaSVM -0.95
- T49R (p.Thr49Arg), gnomAD rs1347271467, REVEL 0.05, MetaLR 0.10
- P50L (p.Pro50Leu), ExAC rs778252640, gnomAD rs778252640, REVEL 0.08, MetaLR 0.08
- P50R (p.Pro50Arg), ExAC rs778252640, gnomAD rs778252640, REVEL 0.04, MetaLR 0.06
- H51Y (p.His51Tyr), TOPMed rs1299679736
- L53M (p.Leu53Met), NCI-TCGA Cosmic COSV6386, cosmic curated COSV63862, Variant assessed as somatic; moderate impact.
- L53R (p.Leu53Arg), Ensembl rs916990656
- S54R (p.Ser54Arg), gnomAD rs1163527213
- E55* (p.Glu55Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P56=, rs553213552, NCI-TCGA Cosmic COSV1008, Variant assessed as somatic; low impact.
- P56L (p.Pro56Leu), rs753367775, ExAC rs753367775, TOPMed rs753367775, gnomAD rs753367775, REVEL 0.09, MetaLR 0.12, Variant assessed as somatic; moderate impact.
- P56S (p.Pro56Ser), Ensembl rs2128746379, REVEL 0.07, MetaLR 0.08
- C57Y (p.Cys57Tyr), cosmic curated COSV63850, TOPMed rs1775327594, REVEL 0.56, MetaLR 0.22
- Q59* (p.Gln59Ter), cosmic curated COSV10652, Ensembl rs1562388720
- Q59P (p.Gln59Pro), ExAC rs778854057, gnomAD rs778854057, REVEL 0.26, MetaLR 0.14
- G60* (p.Gly60Ter), cosmic curated COSV10087, TOPMed rs1775326733, CADD 41.00
- G60E (p.Gly60Glu), rs1251092701, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, gnomAD rs1251092701, REVEL 0.58, MetaLR 0.49, Variant assessed as somatic; moderate impact.
- C61Y (p.Cys61Tyr), TOPMed rs1020449619, gnomAD rs1020449619, REVEL 0.76, MetaLR 0.53
- H62Q (p.His62Gln), ExAC rs757191782, TOPMed rs757191782, gnomAD rs757191782, REVEL 0.08, MetaLR 0.03, Uncertain significance, not specified
- F63L (p.Phe63Leu), Ensembl rs1775325640, MetaLR 0.13, MetaSVM -0.77
- W64* (p.Trp64Ter), rs1219188453, cosmic curated COSV10468, TOPMed rs1219188453, gnomAD rs1219188453, CADD 40.00, Variant assessed as somatic; high impact.
- N65S (p.Asn65Ser), rs1346089547, NCI-TCGA Cosmic COSV6385, cosmic curated COSV63857, gnomAD rs1346089547, REVEL 0.09, MetaLR 0.14, Variant assessed as somatic; moderate impact.
- V67A (p.Val67Ala), Ensembl rs758953330, REVEL 0.05, MetaLR 0.06
- V67I (p.Val67Ile), Ensembl rs2128744294, REVEL 0.10, MetaLR 0.11
- D68Y (p.Asp68Tyr), gnomAD rs1285596214, REVEL 0.39, MetaLR 0.21
- Q69E (p.Gln69Glu), TOPMed rs1775324534, gnomAD rs1775324534, REVEL 0.23, MetaLR 0.26
- Q69L (p.Gln69Leu), TOPMed rs1775324307, MetaLR 0.28, MetaSVM -0.47
- N71H (p.Asn71His), ExAC rs753306008, gnomAD rs753306008, REVEL 0.09, MetaLR 0.13
- C72* (p.Cys72Ter), TOPMed rs1241089279, CADD 39.00
- C72R (p.Cys72Arg), NCI-TCGA Cosmic COSV6385, cosmic curated COSV63856, REVEL 0.76, MetaLR 0.65, Variant assessed as somatic; moderate impact.
- A73G (p.Ala73Gly), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, NCI-TCGA Cosmic COSV6386, MetaLR 0.13, MetaSVM -0.94, Variant assessed as somatic; moderate impact.
- L74V (p.Leu74Val), ExAC rs777286880, gnomAD rs777286880
- K75* (p.Lys75Ter), Ensembl rs1775322732, CADD 36.00
- C76R (p.Cys76Arg), ExAC rs755740564, gnomAD rs755740564, REVEL 0.72, MetaLR 0.42, Uncertain significance, not specified
- C76Y (p.Cys76Tyr), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, REVEL 0.65, MetaLR 0.49, Variant assessed as somatic; moderate impact.
- R77P (p.Arg77Pro), ESP rs140860347, ExAC rs140860347, gnomAD rs140860347
- R77Q (p.Arg77Gln), cosmic curated COSV10442, ESP rs140860347, ExAC rs140860347, gnomAD rs140860347
- R77W (p.Arg77Trp), cosmic curated COSV63852, ExAC rs746684942, TOPMed rs746684942, gnomAD rs746684942, MetaLR 0.28, MetaSVM -0.54
- E78K (p.Glu78Lys), NCI-TCGA Cosmic COSV1008, Variant assessed as somatic; moderate impact.
- E78Q (p.Glu78Gln), ExAC rs758893022, TOPMed rs758893022, Uncertain significance, not specified
- S79L (p.Ser79Leu), cosmic curated COSV63860, 1000Genomes rs150941257, ESP rs150941257, ExAC rs150941257, MetaLR 0.33, MetaSVM -0.33
- C80R (p.Cys80Arg), ExAC rs757736576, TOPMed rs757736576, gnomAD rs757736576, Uncertain significance, not specified
- C80W (p.Cys80Trp), rs1774738285, ClinGen CA365447814, ClinVar RCV004204099, TOPMed rs1774738285, AlphaMissense 0.85, MetaLR 0.63, Uncertain significance, not specified
- E81D (p.Glu81Asp), TOPMed rs1373871205, MetaLR 0.15, MetaSVM -0.96
- V82G (p.Val82Gly), gnomAD rs1405807699
- V82I (p.Val82Ile), TOPMed rs1774737792
- G83D (p.Gly83Asp), Ensembl rs2128735130, MetaLR 0.18, MetaSVM -0.86
- C84F (p.Cys84Phe), cosmic curated COSV10747, ExAC rs753907292, TOPMed rs753907292, gnomAD rs753907292, REVEL 0.03, MetaLR 0.19
- C84Y (p.Cys84Tyr), ExAC rs753907292, TOPMed rs753907292, gnomAD rs753907292, REVEL 0.02, MetaLR 0.17
- S85I (p.Ser85Ile), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Ensembl rs1774736707, Variant assessed as somatic; moderate impact.
- S85R (p.Ser85Arg), ESP rs369171859, ExAC rs369171859, TOPMed rs369171859, gnomAD rs369171859, MetaLR 0.30, MetaSVM -0.59
- S86G (p.Ser86Gly), ExAC rs775755714, TOPMed rs775755714, gnomAD rs775755714
- S86N (p.Ser86Asn), cosmic curated COSV63861, Ensembl rs2128735094
- S86R (p.Ser86Arg), 1000Genomes rs545356487, ExAC rs545356487, TOPMed rs545356487, gnomAD rs545356487
- A87G (p.Ala87Gly), ESP rs145609658, ExAC rs145609658, TOPMed rs145609658, gnomAD rs145609658
- A87T (p.Ala87Thr), rs376101389, NCI-TCGA Cosmic COSV6385, cosmic curated COSV63853, ESP rs376101389, AlphaMissense 0.10, MetaLR 0.19, Variant assessed as somatic; moderate impact.
- A87V (p.Ala87Val), rs145609658, NCI-TCGA Cosmic COSV6386, cosmic curated COSV63861, ESP rs145609658, AlphaMissense 0.13, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- E88A (p.Glu88Ala), TOPMed rs1295924873, gnomAD rs1295924873
- E88G (p.Glu88Gly), TOPMed rs1295924873, gnomAD rs1295924873
- E88K (p.Glu88Lys), cosmic curated COSV10468, Ensembl rs2128735058
- G89C (p.Gly89Cys), Ensembl rs2128735041
- G89S (p.Gly89Ser), cosmic curated COSV10889, Ensembl rs2128735041
- A90T (p.Ala90Thr), TOPMed rs1774733694
- A90V (p.Ala90Val), Ensembl rs2128735022, MetaLR 0.22, MetaSVM -0.75
- E92K (p.Glu92Lys), cosmic curated COSV63862, Ensembl rs2128735018
- E92Q (p.Glu92Gln), NCI-TCGA Cosmic COSV6386, Variant assessed as somatic; moderate impact.
- E93G (p.Glu93Gly), TOPMed rs1202390995, gnomAD rs1202390995
- E93K (p.Glu93Lys), TOPMed rs1774733223
- E93V (p.Glu93Val), TOPMed rs1202390995, gnomAD rs1202390995, MetaLR 0.50, MetaSVM 0.06
- E94A (p.Glu94Ala), cosmic curated COSV63859, 1000Genomes rs576811751, ExAC rs576811751, gnomAD rs576811751
- E94K (p.Glu94Lys), cosmic curated COSV63857, TOPMed rs373938735, gnomAD rs373938735
- E94Q (p.Glu94Gln), TOPMed rs373938735, gnomAD rs373938735
- V95I (p.Val95Ile), TOPMed rs1774731684, MetaLR 0.07, MetaSVM -1.03
- L96V (p.Leu96Val), Ensembl rs1562379765, MetaLR 0.27, MetaSVM -0.71
- E97* (p.Glu97Ter), ExAC rs771857560, TOPMed rs771857560, gnomAD rs771857560
- E97K (p.Glu97Lys), ExAC rs771857560, TOPMed rs771857560, gnomAD rs771857560
- N98D (p.Asn98Asp), gnomAD rs1386947086
- N98K (p.Asn98Lys), ExAC rs771802350, TOPMed rs771802350, gnomAD rs771802350, cosmic curated COSV10087
- N98Y (p.Asn98Tyr), gnomAD rs1386947086
- A99E (p.Ala99Glu), TOPMed rs1226977360, gnomAD rs1226977360
- A99P (p.Ala99Pro), Ensembl rs2128727040
- A99V (p.Ala99Val), cosmic curated COSV63860, TOPMed rs1226977360, gnomAD rs1226977360, REVEL 0.07, MetaLR 0.14
- D100A (p.Asp100Ala), Ensembl rs1582866217
- D100E (p.Asp100Glu), Ensembl rs2128727007
- D100H (p.Asp100His), Ensembl rs2128727016
- D100V (p.Asp100Val), Ensembl rs1582866217
- D100Y (p.Asp100Tyr), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Ensembl rs2128727016, Variant assessed as somatic; moderate impact.
- L101I (p.Leu101Ile), 1000Genomes rs532503107, ExAC rs532503107, gnomAD rs532503107, MetaLR 0.18, MetaSVM -0.83
- T103A (p.Thr103Ala), ExAC rs771267442, TOPMed rs771267442, gnomAD rs771267442
- T103I (p.Thr103Ile), Ensembl rs2128726979
- T103P (p.Thr103Pro), ExAC rs771267442, TOPMed rs771267442, gnomAD rs771267442
- T103S (p.Thr103Ser), ExAC rs771267442, TOPMed rs771267442, gnomAD rs771267442, MetaLR 0.15, MetaSVM -0.82
- A104D (p.Ala104Asp), gnomAD rs1774226659
- A104P (p.Ala104Pro), Ensembl rs2128726964
- A104T (p.Ala104Thr), Ensembl rs2128726964
- A104V (p.Ala104Val), gnomAD rs1774226659
- P105A (p.Pro105Ala), Ensembl rs1774226111
- P105L (p.Pro105Leu), cosmic curated COSV63861, ExAC rs767519397, TOPMed rs767519397, gnomAD rs767519397
- P105R (p.Pro105Arg), ExAC rs767519397, TOPMed rs767519397, gnomAD rs767519397
- P105S (p.Pro105Ser), Ensembl rs1774226111, MetaLR 0.21, MetaSVM -0.68
- F106I (p.Phe106Ile), Ensembl rs2128726920
- F106L (p.Phe106Leu), Ensembl rs2128726920
- F106V (p.Phe106Val), Ensembl rs2128726920
- A107D (p.Ala107Asp), TOPMed rs1774224661
- A107T (p.Ala107Thr), ExAC rs752731431, gnomAD rs752731431, MetaLR 0.06, MetaSVM -1.01
- S108C (p.Ser108Cys), ExAC rs781268704, TOPMed rs781268704, gnomAD rs781268704
- S108F (p.Ser108Phe), ExAC rs781268704, TOPMed rs781268704, gnomAD rs781268704
- S108T (p.Ser108Thr), Ensembl rs2128726906
Public ROS1 analysis runs
- ROS1 analysis run — ROS1 (5,943 variants) — completed 2026-08-18